09 Oct 2025 | 5 Mins Read
Delhi HC lets Natco sell generic Risdiplam, rejects Roche's request
Flipitmoney
The Delhi High Court dismissed a plea by F. Hoffmann-La Roche to stop Natco Pharma from selling its generic version of Risdiplam, used to treat spinal muscular atrophy (SMA). The court allowed Natco to sell its version at ₹15,900 per bottle, significantly cheaper than Roche's ₹600,000 price. The judgement upholds a public interest priority due to the disease's rarity.